# Shilpa Medicare Limited – FDA Inspection, Mar 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/9391676a-8df7-457f-a6e9-67c198678aa7
Source feed: FDA_Inspections

> FDA inspection 1202016 of Shilpa Medicare Limited, March 10, 2023. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202016
- Company Name: Shilpa Medicare Limited
- Inspection Date: 2023-03-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1336256 - 2026-09-18](https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/6376e9c8-6b0c-4036-a44a-a521101dcb97)

## Related Officers

- [Alan L. Truong](https://www.keypedia.com/people/alan-l-truong/8b9c59ed-ce68-44c3-9fbe-07cc3da13713)
- [Issuing Officer](https://www.keypedia.com/people/joan-m-cantellops-figueroa/f791fcd2-a5d4-41e8-a8f2-96569096b422)

Company: https://www.keypedia.com/companies/shilpa-medicare-limited/c219df48-2c30-498e-b9db-1d4d3c33ef2d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c